ROSELLA (GOG3073, engotov72, APGOT-OV10): a phase 3 study of relacorilant + nab-paclitaxel in patients with platinum-resistant ovarian cancer

Domenica Lorusso; Stanislas Quesada; John K. Chan; Jung-Yun Lee; Mariana Scaranti; Vanda Salutari; Carolyn Y. Muller; Linda Mileshkin; Toon Van Gorp; Lyndsay Willmott; et al.

doi:10.1016/j.ijgc.2025.104426

Back

ROSELLA (GOG3073, engotov72, APGOT-OV10): a phase 3 study of relacorilant + nab-paclitaxel in patients with platinum-resistant ovarian cancer

Journal article

Peer reviewed

ROSELLA (GOG3073, engotov72, APGOT-OV10): a phase 3 study of relacorilant + nab-paclitaxel in patients with platinum-resistant ovarian cancer

Domenica Lorusso, Stanislas Quesada, John K. Chan, Jung-Yun Lee, Mariana Scaranti, Vanda Salutari, Carolyn Y. Muller, Linda Mileshkin, Toon Van Gorp, Lyndsay Willmott, …

International journal of gynecological cancer, Vol.36(2), p.104426

02/2026

DOI: https://doi.org/10.1016/j.ijgc.2025.104426

Metrics

1 Record Views

Details

Title: ROSELLA (GOG3073, engotov72, APGOT-OV10): a phase 3 study of relacorilant + nab-paclitaxel in patients with platinum-resistant ovarian cancer
Creators: Domenica Lorusso
Stanislas Quesada
John K. Chan
Jung-Yun Lee
Mariana Scaranti
Vanda Salutari
Carolyn Y. Muller
Linda Mileshkin
Toon Van Gorp
Lyndsay Willmott
et al.
Publication Details: International journal of gynecological cancer, Vol.36(2), p.104426
Identifiers: 991006256541802656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article

ROSELLA (GOG3073, engotov72, APGOT-OV10): a phase 3 study of relacorilant + nab-paclitaxel in patients with platinum-resistant ovarian cancer

Related links

Metrics

Details